17β-Estradiol stimulates a rapid Ca2+ influx in LNCaP human prostate cancer cells

European Journal of Endocrinology

Volumn 135, Issue 3, 1996, Pages 367-373

  Audy, M C ^a   Vacher, P ^a   Dufy, B ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; ESTRADIOL; FLUTAMIDE; TAMOXIFEN;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 0029909596     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1350367     Document Type: Article

References (39)

1. 2+ in single rat hepatocytes. Biochem J 1991;280:273-6
2. Morley P, Whitfield JF, Vanderhyden BC, Tsang BK, Schwartz L. A new, non genomic estrogen action: the rapid release of intracellular calcium. Endocrinology 1992; 161: 1305-12
3. Sadler SE, Maller JL. Identification of a steroid receptor on the surface of Xenopus oocytes by photoaffinity labelling. J Biol Chem 1982;257:355-61
4. Blackmore PF, Neulen J, Lattanzio K, Beebe SJ. Cell surface-binding sites for progesterone mediate calcium uptake in human sperm. J Biol Chem 1991;266:18655-59
5. Batra S. Increase by oestrogen of calcium entry and calcium channel density in uterine smooth muscle. Br J Pharmacol 1987;92:389-92
6. 3 on the phosphoinositide metabolism. J Biol Chem 1989;264:20403-6
7. 3 metabolites on cytosolic free calcium in confluent mouse osteoblasts. J Biol Chem 1987;262: 13168-73
8. Steinsapir J, Socci R, Reinach P. Effects of androgen on intracellular calcium of LNCaP cells. Bioch Biophys Res Commun 1991;179:90-6
9. Horoszewics JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu MT, et al. LNCaP model of human prostatic carcinoma. Cancer Res 1983;43:1809-18
10. Schurmans ALG, Bolt J, Voorhorst MM, Blankenstein RA, Mulder E. Regulation of growth and epidermal growth factor receptor levels of LNCaP prostate tumor cells by different steroids. Int J Cancer 1988;43:917-22
11. Veldscholte J, Ris-Stalpers C, Kuiper GGJM, Jenster G, Berrevoets C, Claassen E, et al. A mutation in the ligand domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens. Biochem Biophys Res Commun 1990;173:534-40
12. Ekman P, Barrack ER, Greene GL, Jensen EV, Washs PC. Estrogen receptors in human prostate: evidence for multiple binding sites. J Clin Endocrinol Metabl 1983;57:166-76
13. Castagnetta LA, Miceli MD, Sorci CMG, Pfeffer U, Farruggio R, Oliveri G, et al. Growth of LNCaP human prostate cancer cells is stimulated by estradiol via its own receptor. Endocrinology 1995; 136:2309-19
14. Durher ACH, Walton JM. Calcium ions and the control of proliferation in normal and cancer cells. Biosci Rep 1982;2:15-30
15. Lieberherr M, Grosse B. Androgens increase intracellular calcium concentration and inositol 1,4,5-triphosphate and diacylglycerol formation via a pertussis toxin-sensitive G protein. J Biol Chem 1994;269:7217-23
16. 2+ transients using simultaneously dual-emission microspectrofluorimetry and electrophysiology in individual pituitary cells. Biochem Biophys Res Commun 1989;164:1045-52
17. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985;260:3440-50
18. Wilding G, Chen M, Gelman E. Aberrant response in vitro of hormone-responsive prostate cancer cells to anti-androgens. Prostate 1989;14:103-15
19. Negri-Cesi P, Motta M, Mornati O. Androgen metabolism in the human prostatic cancer cell line LNCaP. J Steroid Biochem Mol Biol 1994;51:89-96
20. Olea N, Sakabe K, Soto AM, Sonnenschein C. The proliferative effect of "anti-androgen" on the androgen-sensitive human prostate tumor cell line LNCaP. Endocrinology 1990;126: 1457-63
21. Crawford ED, DeAntonio EP, Labrie E, Schroder FH, Geller J. Therapeutic controversies: endocrine therapy of prostate cancer: optimal form and appropriate timing. J Clin Endocrinol Metab 1995;80:1062-78
22. Chung L., Sutkowski DM, Sensibar JA, Zelner D, Kim I, Amsel I, et al. Regulation of proliferation and production of prostate-specific antigen in androgen-sensitive prostatic cancer cells. LNCaP by dihydrotestosterone. Endocrinology 1995;136:796-803
23. Carruba G, Pfeffer U, Fecarotta E, Coviello DA, D'Amato E, Lo Casto M, et al. Estradiol inhibits growth of hormone-nonresponsive PC3 human prostate cancer cells. Cancer Res 1994;54:1190-3
24. Labrie F, Dupont A, Belanger A, Cusan L, Lacourciere Y, Monfette G, et al. New hormonal therapy in prostatic carcinoma: combined treatment with an GnRH agonist and an antiandrogen. J Clin Invest Med 1982;5:267-75
25. Labrie F, Dupont A, Belanger A, St-Arnaud R, Giguere M, Lacourciere Y, et al. Treatment of prostate cancer with gonadotropin-releasing hormone agonists. Endocr Rev 1986; 7:67-74
26. Schroder FB. Endocrine therapy for prostate cancer: recent developments and current status. Br J Urol 1993;71:633-40
27. Wilding G. The importance of steroid hormones in prostate cancer. Cancer Surv 1992;14:113-30
28. Donnelly BJ, Lakey WH, McBlain WA. Estrogen receptor in human benign prostatic hyperplasia. J Urol 1983;130:183-7
29. Picard D, Kumar V, Chambon P, Yamamoto KR. Signal transduction by steroid hormones: nuclear localization is differentially regulated in estrogen and glucocorticoid receptors. Cell Regul 1990;1:291-9
30. Gorczynska E, Handelsman DJ. Androgens rapidly increase the cytosolic calcium concentration in Sertoli cells. Endocrinology 1995;136:2052-9
31. Sartor P, Vacher P, Mollard P, Dufy B. Tamoxifen reduces calcium currents in a clonal pituitary cell line. Endocrinology 1988; 123:534-40
32. Schumacher M. Rapid membrane effects of steroid hormones: an emerging concept in neuroendocrinology. TINS 1990;13:359-62
33. Rasmussen H. Les ions calcium messagers intracellulaires. Science 1989;146:86-92
34. Berridge MJ, Irvine RF. Inositol phosphates and cell signalling. Nature 1989;341:187-205
35. Berridge MJ. Calcium oscillations. J Biol Chem 1990;265:9583-6
36. Putney WJ, Bird GJ. The inositol phosphate-calcium signaling system in non excitable cells. Endocr Rev 1993;14:610-31
37. Widmark A, Grankvist K, Bergh A, Henriksson R, Damber JE. Effects of estrogens and progestogens on the membrane permeability and growth of human prostatic carcinoma cells (PC-3) in vitro. Prostate 1995;26:5-11
38. Daehlin L. Estrogen inhibits proliferation of the human prostatic carcinoma cell line PC-3. Exp Clin Endocrinol 1992;11:171-3
39. Westin P, Brändström A, Damber JE, Bergh A. Castration plus oestrogen treatment induces but castration alone suppresses epithelial cell apoptosis in an androgen-sensitive rat prostatic adenocarcinoma. Br J Cancer 1995;72:140-5